Natalizumab is FDA-approved for the treatment of multiple sclerosis and Crohn's disease and approved for treatment of multiple sclerosis in Europe. Pre-clinical evidence suggests that it could be also used in combination for the treatment of B-cell malignancies where it overcomes the resistance to rituximab.
â¢ Maintains the security of the Dietary Department. â¢ Is responsible for knowing, understanding, and conveying to other dietary staff personnel the Federal and State rules and regulations regarding nursing home dietary requir ements and is responsible for their enforcement within the scope of the Dietary Department.
Upon completion of a dietary manager certificate program, individuals are eligible to take the national credentialing exam administered by the Dietary Managers Association (DMA). Students considering this type of online program may look for programs that are approved by the DMA.